Ernexa Therapeutics Inc.
ERNA
$4.27
-$0.03-0.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.03M | 9.18M | 1.88M | 3.05M | 4.32M |
| Total Receivables | 83.00K | 95.00K | 845.00K | 153.00K | 154.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 783.00K | 724.00K | 404.00K | 179.00K | 323.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 5.89M | 10.00M | 3.13M | 3.38M | 4.79M |
|
|
|||||
| Total Current Assets | 5.89M | 10.00M | 3.13M | 3.38M | 4.79M |
| Net Property, Plant & Equipment | 396.00K | 437.00K | 547.00K | 633.00K | 631.00K |
| Long-term Investments | -- | -- | 2.04M | 2.04M | 2.04M |
| Goodwill | -- | -- | 2.04M | 2.04M | 2.04M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 25.00K | 110.00K | 110.00K | 116.00K | 117.00K |
| Total Assets | 6.32M | 10.54M | 5.83M | 6.17M | 7.58M |
|
|
|||||
| Total Accounts Payable | 1.38M | 1.30M | 1.13M | 958.00K | 1.32M |
| Total Accrued Expenses | 1.02M | 1.48M | 562.00K | 829.00K | 908.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 167.00K | 163.00K | 213.00K | 206.00K | 217.00K |
| Total Finance Division Other Current Liabilities | 374.00K | 513.00K | 1.21M | 151.00K | 207.00K |
| Total Other Current Liabilities | 374.00K | 513.00K | 1.21M | 151.00K | 207.00K |
| Total Current Liabilities | 2.93M | 3.46M | 3.11M | 2.14M | 2.65M |
|
|
|||||
| Total Current Liabilities | 2.93M | 3.46M | 3.11M | 2.14M | 2.65M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 182.00K | 226.00K | 277.00K | 346.00K | 376.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.00K | 1.00K | 43.00K | 112.00K | 113.00K |
| Total Liabilities | 3.12M | 3.68M | 3.43M | 2.60M | 3.14M |
|
|
|||||
| Common Stock & APIC | 258.36M | 258.00M | 248.04M | 247.70M | 247.33M |
| Retained Earnings | -255.16M | -251.14M | -245.64M | -244.13M | -242.89M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 3.20M | 6.86M | 2.40M | 3.57M | 4.44M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
|
|
|||||
| Total Common Equity | 3.20M | 6.86M | 2.40M | 3.57M | 4.44M |
| Total Preferred Equity | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.20M | 6.86M | 2.40M | 3.57M | 4.44M |
|
|
|||||